Cargando…

Appropriately smoothing prevalence data to inform estimates of growth rate and reproduction number

The time-varying reproduction number ([Formula: see text]) can change rapidly over the course of a pandemic due to changing restrictions, behaviours, and levels of population immunity. Many methods exist that allow the estimation of [Formula: see text] from case data. However, these are not easily a...

Descripción completa

Detalles Bibliográficos
Autores principales: Eales, Oliver, Ainslie, Kylie E.C., Walters, Caroline E., Wang, Haowei, Atchison, Christina, Ashby, Deborah, Donnelly, Christl A., Cooke, Graham, Barclay, Wendy, Ward, Helen, Darzi, Ara, Elliott, Paul, Riley, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220254/
https://www.ncbi.nlm.nih.gov/pubmed/35780515
http://dx.doi.org/10.1016/j.epidem.2022.100604
_version_ 1784732328030896128
author Eales, Oliver
Ainslie, Kylie E.C.
Walters, Caroline E.
Wang, Haowei
Atchison, Christina
Ashby, Deborah
Donnelly, Christl A.
Cooke, Graham
Barclay, Wendy
Ward, Helen
Darzi, Ara
Elliott, Paul
Riley, Steven
author_facet Eales, Oliver
Ainslie, Kylie E.C.
Walters, Caroline E.
Wang, Haowei
Atchison, Christina
Ashby, Deborah
Donnelly, Christl A.
Cooke, Graham
Barclay, Wendy
Ward, Helen
Darzi, Ara
Elliott, Paul
Riley, Steven
author_sort Eales, Oliver
collection PubMed
description The time-varying reproduction number ([Formula: see text]) can change rapidly over the course of a pandemic due to changing restrictions, behaviours, and levels of population immunity. Many methods exist that allow the estimation of [Formula: see text] from case data. However, these are not easily adapted to point prevalence data nor can they infer [Formula: see text] across periods of missing data. We developed a Bayesian P-spline model suitable for fitting to a wide range of epidemic time-series, including point-prevalence data. We demonstrate the utility of the model by fitting to periodic daily SARS-CoV-2 swab-positivity data in England from the first 7 rounds (May 2020–December 2020) of the REal-time Assessment of Community Transmission-1 (REACT-1) study. Estimates of [Formula: see text] over the period of two subsequent rounds (6–8 weeks) and single rounds (2–3 weeks) inferred using the Bayesian P-spline model were broadly consistent with estimates from a simple exponential model, with overlapping credible intervals. However, there were sometimes substantial differences in point estimates. The Bayesian P-spline model was further able to infer changes in [Formula: see text] over shorter periods tracking a temporary increase above one during late-May 2020, a gradual increase in [Formula: see text] over the summer of 2020 as restrictions were eased, and a reduction in [Formula: see text] during England’s second national lockdown followed by an increase as the Alpha variant surged. The model is robust against both under-fitting and over-fitting and is able to interpolate between periods of available data; it is a particularly versatile model when growth rate can change over small timescales, as in the current SARS-CoV-2 pandemic. This work highlights the importance of pairing robust methods with representative samples to track pandemics.
format Online
Article
Text
id pubmed-9220254
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Authors. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-92202542022-06-23 Appropriately smoothing prevalence data to inform estimates of growth rate and reproduction number Eales, Oliver Ainslie, Kylie E.C. Walters, Caroline E. Wang, Haowei Atchison, Christina Ashby, Deborah Donnelly, Christl A. Cooke, Graham Barclay, Wendy Ward, Helen Darzi, Ara Elliott, Paul Riley, Steven Epidemics Article The time-varying reproduction number ([Formula: see text]) can change rapidly over the course of a pandemic due to changing restrictions, behaviours, and levels of population immunity. Many methods exist that allow the estimation of [Formula: see text] from case data. However, these are not easily adapted to point prevalence data nor can they infer [Formula: see text] across periods of missing data. We developed a Bayesian P-spline model suitable for fitting to a wide range of epidemic time-series, including point-prevalence data. We demonstrate the utility of the model by fitting to periodic daily SARS-CoV-2 swab-positivity data in England from the first 7 rounds (May 2020–December 2020) of the REal-time Assessment of Community Transmission-1 (REACT-1) study. Estimates of [Formula: see text] over the period of two subsequent rounds (6–8 weeks) and single rounds (2–3 weeks) inferred using the Bayesian P-spline model were broadly consistent with estimates from a simple exponential model, with overlapping credible intervals. However, there were sometimes substantial differences in point estimates. The Bayesian P-spline model was further able to infer changes in [Formula: see text] over shorter periods tracking a temporary increase above one during late-May 2020, a gradual increase in [Formula: see text] over the summer of 2020 as restrictions were eased, and a reduction in [Formula: see text] during England’s second national lockdown followed by an increase as the Alpha variant surged. The model is robust against both under-fitting and over-fitting and is able to interpolate between periods of available data; it is a particularly versatile model when growth rate can change over small timescales, as in the current SARS-CoV-2 pandemic. This work highlights the importance of pairing robust methods with representative samples to track pandemics. The Authors. Published by Elsevier B.V. 2022-09 2022-06-22 /pmc/articles/PMC9220254/ /pubmed/35780515 http://dx.doi.org/10.1016/j.epidem.2022.100604 Text en © 2022 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Eales, Oliver
Ainslie, Kylie E.C.
Walters, Caroline E.
Wang, Haowei
Atchison, Christina
Ashby, Deborah
Donnelly, Christl A.
Cooke, Graham
Barclay, Wendy
Ward, Helen
Darzi, Ara
Elliott, Paul
Riley, Steven
Appropriately smoothing prevalence data to inform estimates of growth rate and reproduction number
title Appropriately smoothing prevalence data to inform estimates of growth rate and reproduction number
title_full Appropriately smoothing prevalence data to inform estimates of growth rate and reproduction number
title_fullStr Appropriately smoothing prevalence data to inform estimates of growth rate and reproduction number
title_full_unstemmed Appropriately smoothing prevalence data to inform estimates of growth rate and reproduction number
title_short Appropriately smoothing prevalence data to inform estimates of growth rate and reproduction number
title_sort appropriately smoothing prevalence data to inform estimates of growth rate and reproduction number
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220254/
https://www.ncbi.nlm.nih.gov/pubmed/35780515
http://dx.doi.org/10.1016/j.epidem.2022.100604
work_keys_str_mv AT ealesoliver appropriatelysmoothingprevalencedatatoinformestimatesofgrowthrateandreproductionnumber
AT ainsliekylieec appropriatelysmoothingprevalencedatatoinformestimatesofgrowthrateandreproductionnumber
AT walterscarolinee appropriatelysmoothingprevalencedatatoinformestimatesofgrowthrateandreproductionnumber
AT wanghaowei appropriatelysmoothingprevalencedatatoinformestimatesofgrowthrateandreproductionnumber
AT atchisonchristina appropriatelysmoothingprevalencedatatoinformestimatesofgrowthrateandreproductionnumber
AT ashbydeborah appropriatelysmoothingprevalencedatatoinformestimatesofgrowthrateandreproductionnumber
AT donnellychristla appropriatelysmoothingprevalencedatatoinformestimatesofgrowthrateandreproductionnumber
AT cookegraham appropriatelysmoothingprevalencedatatoinformestimatesofgrowthrateandreproductionnumber
AT barclaywendy appropriatelysmoothingprevalencedatatoinformestimatesofgrowthrateandreproductionnumber
AT wardhelen appropriatelysmoothingprevalencedatatoinformestimatesofgrowthrateandreproductionnumber
AT darziara appropriatelysmoothingprevalencedatatoinformestimatesofgrowthrateandreproductionnumber
AT elliottpaul appropriatelysmoothingprevalencedatatoinformestimatesofgrowthrateandreproductionnumber
AT rileysteven appropriatelysmoothingprevalencedatatoinformestimatesofgrowthrateandreproductionnumber